Lysophosphatidic 酸降低了在皮细胞衍生细胞系中的人类 RIPK4 mRNA 的下调
Lei Xu1, Peter Bajorski2, Brian Poligone1
1Rochester General Hospital Research Institute, Cancer Biology Research, Rochester, New York, United States of America.
PloS one
|April 17, 2024
概括
Lysophosphatidic 酸 (LPA) 抑制了氨酸-氨酸激酶 RIPK4,增加了角质细胞的增殖. 这一发现可能解释状细胞癌 (SCC) 中RIPK4的下调,并提供治疗点.
科学领域:
- 皮肤病学 皮肤病学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 角质细胞的增殖对于皮肤屏障功能,伤口愈合和瘤形成至关重要.
- 氨酸-氨酸激酶RIPK4对于调节角质细胞增殖至关重要.
- 失去RIPK4功能与状细胞癌 (SCC) 的发展有关.
研究的目的:
- 调查RIPK4在角质细胞增殖中的作用.
- 为了确定RIPK4.4的生物调节剂.
- 阐明SCC中RIPK4下调的机制.
主要方法:
- 研究了 lysophosphatidic acid (LPA) 对 RIPK4 表达和角质细胞增殖的影响.
- 使用了具有不同RIPK4表达水平的细胞培养模型.
主要成果:
- 溶解酸 (LPA) 是一种血清脂,被确定为RIPK4的生物抑制剂.
- 通过抑制其mRNA转录,LPA抑制RIPK4.
- 治疗LPA增加了角质细胞的增殖,这种效应在减少RIPK4.4的细胞中减弱.
结论:
- LPA对RIPK4产生负面调节,影响着角质细胞的增殖.
- 这项研究提供了关于RIPK4在SCC进展中的作用的见解.
- 使用LPA等血清成分准RIPK4可能为皮肤疾病提供新的治疗策略.
更多相关视频
09:15Tyramide Signal Amplification for the Immunofluorescent Staining of ZBP1-Dependent Phosphorylation of RIPK3 and MLKL After HSV-1 Infection in Human Cells
Published on: October 20, 2022
2.2K
07:29Characterization of In Vitro Differentiation of Human Primary Keratinocytes by RNA-Seq Analysis
Published on: May 16, 2020
6.1K
相关概念视频
The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
Phosphoinositides and PIPs
8.5K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.5K
IP3/DAG Signaling Pathway
12.0K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.0K
MAPK Signaling Cascades
5.5K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K
